Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Salvage operation for late recurrence after stereotactic body radiotherapy for lung cancer: two patients with no viable cancer cells.

Taira N, Kawabata T, Ichi T, Kushi K, Yohena T, Kawasaki H, Ishikawa K, Kato S.

Ann Thorac Surg. 2014 Jun;97(6):2167-71. doi: 10.1016/j.athoracsur.2013.07.123.

PMID:
24882296
2.

Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.

Neri S, Takahashi Y, Terashi T, Hamakawa H, Tomii K, Katakami N, Kokubo M.

J Thorac Oncol. 2010 Dec;5(12):2003-7. doi: 10.1097/JTO.0b013e3181f8a785.

3.

Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Dunlap NE, Yang W, McIntosh A, Sheng K, Benedict SH, Read PW, Larner JM.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1071-7. doi: 10.1016/j.ijrobp.2012.01.088. Epub 2012 Aug 14.

PMID:
22898383
4.

Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer.

Takeda A, Sanuki N, Eriguchi T, Enomoto T, Yokosuka T, Kaneko T, Handa H, Aoki Y, Oku Y, Kunieda E.

Ann Thorac Surg. 2013 Nov;96(5):1776-82. doi: 10.1016/j.athoracsur.2013.06.014. Epub 2013 Aug 30.

PMID:
23998410
5.

Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.

Coon D, Gokhale AS, Burton SA, Heron DE, Ozhasoglu C, Christie N.

Clin Lung Cancer. 2008 Jul;9(4):217-21. doi: 10.3816/CLC.2008.n.032.

PMID:
18650169
6.

Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy.

Essler M, Wantke J, Mayer B, Scheidhauer K, Bundschuh RA, Haller B, Astner ST, Molls M, Andratschke N.

Strahlenther Onkol. 2013 Jun;189(6):495-501. doi: 10.1007/s00066-013-0310-9. Epub 2013 Apr 24.

PMID:
23609133
7.

Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT.

Nishimura S, Takeda A, Sanuki N, Yoshida S, Shigematsu N.

J Thorac Oncol. 2015 Aug;10(8):e69-71. doi: 10.1097/JTO.0000000000000543. No abstract available.

PMID:
26200281
8.

Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.

Bauman JE, Mulligan MS, Martins RG, Kurland BF, Eaton KD, Wood DE.

Ann Thorac Surg. 2008 Nov;86(5):1632-8; discussion 1638-9. doi: 10.1016/j.athoracsur.2008.07.042.

PMID:
19049763
9.

Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.

Hamamoto Y, Kataoka M, Yamashita M, Nogami N, Sugawara Y, Kozuki T, Sawada S, Suehisa H, Shinohara S, Nakajima N, Shinkai T.

Jpn J Radiol. 2012 Oct;30(8):671-5. doi: 10.1007/s11604-012-0107-2. Epub 2012 Jul 20.

PMID:
22836906
10.

High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer.

Huang K, Senthi S, Palma DA, Spoelstra FO, Warner A, Slotman BJ, Senan S.

Radiother Oncol. 2013 Oct;109(1):51-7. doi: 10.1016/j.radonc.2013.06.047. Epub 2013 Aug 13.

11.

Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.

Ebright MI, Russo GA, Gupta A, Subramaniam RM, Fernando HC, Kachnic LA.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):709-15. doi: 10.1016/j.jtcvs.2012.12.024. Epub 2013 Jan 12.

PMID:
23317944
12.

New territory: surgical salvage for stereotactic body radiation therapy failures in lung cancer.

Bradley J.

J Thorac Oncol. 2010 Dec;5(12):1879-80. doi: 10.1097/JTO.0b013e318200dea6. No abstract available.

13.

Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.

Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD.

Acta Oncol. 2013 Jun;52(5):910-8. doi: 10.3109/0284186X.2012.731525. Epub 2012 Oct 29.

PMID:
23106174
14.

Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer.

Kim JH, Kim MS, Yoo SY, Lim SM, Lee GH, Yi KH.

Otolaryngol Head Neck Surg. 2010 Mar;142(3):338-43. doi: 10.1016/j.otohns.2009.12.034.

PMID:
20172377
15.

Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).

Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K.

Cancer. 2007 Jul 1;110(1):148-55.

16.

Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.

Takeda A, Kunieda E, Fujii H, Yokosuka N, Aoki Y, Oooka Y, Oku Y, Ohashi T, Sanuki N, Mizuno T, Ozawa Y.

Lung Cancer. 2013 Mar;79(3):248-53. doi: 10.1016/j.lungcan.2012.11.008. Epub 2012 Dec 11.

PMID:
23246123
17.

Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer.

Takeda A, Kunieda E, Takeda T, Tanaka M, Sanuki N, Fujii H, Shigematsu N, Kubo A.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1057-65. Epub 2007 Oct 1.

PMID:
17905527
18.
19.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
20.

Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma.

Chua DT, Sham JS, Hung KN, Kwong DL, Kwong PW, Leung LH.

Head Neck. 1999 Oct;21(7):620-6.

PMID:
10487949
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk